Health
Research uncovers potential cause of neurotoxicity due to immunotherapy – News-Medical.Net
New research has uncovered the previously unknown presence of CD19 — a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma — in brain cells that protect the blood brain barrier (…
Reviewed by Emily Henderson, B.Sc.Sep 21 2020
New research has uncovered the previously unknown presence of CD19 — a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma — in brain cells that protect the blood brain barrier (BBB).
This discovery may potentially be the cause for neurotoxicity in patients undergoing CD19 directed CAR T cell immunotherapy, according to the research team led by Avery Posey, PhD, an ass…
-
Noosa News16 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News23 hours agoAbout 90,000 households remain without power after severe storms with giant hail lash south-east Queensland
-
General17 hours agoLabor to squeeze public service, sparking warnings of job losses
-
General19 hours agoSister Kate’s site to become home to Perth’s first Aboriginal aged care facility